Cargando…

Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life

Growing evidence suggests that non-motor symptoms (NMS) in Parkinson’s disease (PD) have differential progression patterns that have a different natural history from motor progression and may be geographically influenced. We conducted a cross-sectional analysis of 1607 PD patients of whom 1327 were...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Wamelen, Daniel J., Sauerbier, Anna, Leta, Valentina, Rodriguez-Blazquez, Carmen, Falup-Pecurariu, Cristian, Rodriguez‐Violante, Mayela, Rizos, Alexandra, Tsuboi, Y., Metta, Vinod, Bhidayasiri, Roongroj, Bhattacharya, Kalyan, Borgohain, Rupam, Prashanth, L. K., Rosales, Raymond, Lewis, Simon, Fung, Victor, Behari, Madhuri, Goyal, Vinay, Kishore, Asha, Lloret, Santiago Perez, Martinez-Martin, Pablo, Chaudhuri, K. Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100281/ https://www.ncbi.nlm.nih.gov/pubmed/33953218 http://dx.doi.org/10.1038/s41598-021-88651-4

Ejemplares similares

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
por: Metta, Vinod, et al.
Publicado: (2023)

Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
por: Leta, Valentina, et al.
Publicado: (2021)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale
por: van Wamelen, Daniel Johannes, et al.
Publicado: (2022)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Spotlight on non-motor symptoms and Covid-19
por: Rota, Silvia, et al.
Publicado: (2022)

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering
por: Rodriguez-Sanchez, Fernando, et al.
Publicado: (2021)

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
por: Rizos, A., et al.
Publicado: (2020)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases
por: Günther, René, et al.
Publicado: (2016)

Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale
por: Cubo, Esther, et al.
Publicado: (2023)

Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests
por: Qamar, Mubasher A., et al.
Publicado: (2023)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Validation of a self‐completed Dystonia Non‐Motor Symptoms Questionnaire
por: Klingelhoefer, Lisa, et al.
Publicado: (2019)

Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
por: Bhidayasiri, Roongroj, et al.
Publicado: (2022)

Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson's Disease
por: Jorge de Saráchaga, Adib, et al.
Publicado: (2015)

Editorial: Measurement Tools for Clinical Assessment, Characterization and Neurorehabilitation of Parkinson's Disease
por: Rodriguez-Blazquez, Carmen, et al.
Publicado: (2021)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
por: Metta, Vinod, et al.
Publicado: (2021)

Non-Motor Symptoms in Cervical Dystonia: A Concept in Evolution
por: Urso, Daniele, et al.
Publicado: (2020)

Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study
por: Bhidayasiri, Roongroj, et al.
Publicado: (2023)

Neurological differential diagnosis : a prioritized approach
por: Bhidayasiri, Roongroj
Publicado: (2005)

Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study
por: Bhidayasiri, Roongroj, et al.
Publicado: (2023)

Non motor symptoms in progressive supranuclear palsy: prevalence and severity
por: Radicati, Fabiana Giada, et al.
Publicado: (2017)

Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
por: Raeder, Vanessa, et al.
Publicado: (2021)

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
por: Jost, Stefanie T., et al.
Publicado: (2021)

Comparison of frequencies of non motor symptoms in Indian Parkinson’s disease patients on medical management versus deep brain stimulation: A case-control study
por: Rukmini Mridula, Kandadai, et al.
Publicado: (2015)

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2022)

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children — are we there yet? A systematic review of randomised controlled trials
por: Ben-Shimol, Shalom, et al.
Publicado: (2014)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson’s Disease in Emiratis and Expatriate Population of United Arab Emirates 2019–2021: The EmPark Study
por: Metta, Vinod, et al.
Publicado: (2022)

Physicians’ role in the determination of fitness to drive in patients with Parkinson’s disease: systematic review of the assessment tools and a call for national guidelines
por: Jitkritsadakul, Onanong, et al.
Publicado: (2016)

How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2019)

Doctor Hope; Calming and Comforting Loneliness in Parkinson’s Disease
por: Virameteekul, Sasivimol, et al.
Publicado: (2022)

We Move or Are We Moved? Unpicking the Origins of Voluntary Movements to Better Understand Semivoluntary Movements
por: Virameteekul, Sasivimol, et al.
Publicado: (2022)

Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report
por: Metta, Vinod, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n4fmrs9raoq0hf3vt9khvigj0p